Expression of Molecular Targets for Tyrosine Kinase Receptor Antagonists in Malignant Endocrine Pancreatic Tumors von FJÄLLSKOG, Marie-Louise H, LEJONKLOU, Margareta H, ÖBERG, Kjell E, ERIKSSON, Barbro K, JANSON, Eva T

Volltext

Is it time to widen the use of somatostatin analogs in neuroendocrine tumors? von Oberg, Kjell E

Volltext

Role of Somatostatins in Gastroenteropancreatic Neuroendocrine Tumor Development and Therapy von Öberg, Kjell E, Reubi, Jean–Claude, Kwekkeboom, Dik J, Krenning, Eric P

Volltext

Chromogranin A and Neuron-Specific Enolase as Prognostic Markers in Patients with Advanced pNET Treated with Everolimus von Yao, James C, Pavel, Marianne, Phan, Alexandria T, Kulke, Matthew H, Hoosen, Sakina, St. Peter, Jessica, Cherfi, Azzeddine, Öberg, Kjell E

Volltext

High-dose treatment with a long-acting somatostatin analogue in patients with advanced midgut carcinoid tumours von WELIN, Staffan V, JANSON, Eva Tiensuu, SUNDIN, Anders, STRIDSBERG, Mats, LAVENIUS, Erik, GRANBERG, Dan, SKOGSEID, Britt, ÖBERG, Kjell E, ERIKSSON, Barbro K

Volltext

Pasireotide (SOM230) shows efficacy and tolerability in the treatment of patients with advanced neuroendocrine tumors refractory or resistant to octreotide LAR: results from a phas... von Kvols, Larry K, Oberg, Kjell E, O'Dorisio, Thomas M, Mohideen, Pharis, de Herder, Wouter W, Arnold, Rudolf, Hu, Ke, Zhang, Yilong, Hughes, Gareth, Anthony, Lowell, Wiedenmann, Bertram

Volltext

Somatostatin induces rapid contraction of neuroendocrine cells von Saras, Jan, Grönberg, Malin, Stridsberg, Mats, Öberg, Kjell E., Janson, Eva T.

Volltext

Malignant Gastric Ghrelinoma with Hyperghrelinemia von Tsolakis, Apostolos V., Portela-Gomes, Guida M., Stridsberg, Mats, Grimelius, Lars, Sundin, Anders, Eriksson, Barbro K., Öberg, Kjell E., Janson, Eva T.

Volltext

Treatment with cisplatin and etoposide in patients with neuroendocrine tumors von Fjällskog, Marie‐Louise H., Granberg, Dan. P. K., Welin, Staffan L. V., Eriksson, Christopher, Kjell E. Öberg, Janson, Eva T., Eriksson, Barbro K.

Volltext

NETTER-1 phase III: Progression-free survival, radiographic response, and preliminary overall survival results in patients with midgut neuroendocrine tumors treated with 177-Lu-Dot... von Strosberg, Jonathan R., Wolin, Edward M., Chasen, Beth, Kulke, Matthew H., Bushnell, David L, Caplin, Martyn E., Baum, Richard P., Kunz, Pamela L., Hobday, Timothy J., Hendifar, Andrew Eugene, Oberg, Kjell E., Lopera Sierra, Maribel, Kwekkeboom, Dik J., Ruszniewski, Philippe B., Krenning, Eric

Volltext

Efficacy of octreotide LAR (OCT) in patients (pts) with advanced neuroendocrine tumors (NET): A post hoc analysis of the placebo (PBO) arm of the phase III RADIANT-2 study with upd... von Strosberg, Jonathan R., Yao, James C., Bajetta, Emilio, Aout, Mounir, Bakker, Bert, Hainsworth, John D., Ruszniewski, Philippe B., Van Cutsem, Eric, Oberg, Kjell E., Pavel, Marianne E.

Volltext

Treatment with Combined Streptozotocin and Liposomal Doxorubicin in Metastatic Endocrine Pancreatic Tumors von Fjällskog, Marie-Louise H., Janson, Eva T., Falkmer, Ursula G., Vatn, Morten H., Öberg, Kjell E., Eriksson, Barbro K.

Volltext

First long-term results on efficacy and safety of long-acting pasireotide in combination with everolimus in patients with advanced carcinoids (NET) of the lung/thymus: Phase II LUN... von Baudin, Eric, Berruti, Alfredo, Giuliano, Mario, Mansoor, Wasat, Bobirca, Catalin, Houtsma, Erik, Fagan, Niamh, Oberg, Kjell E., Ferolla, Piero

Volltext

Pivotal phase III COMPOSE trial will compare 177 Lu-edotreotide with best standard of care for well-differentiated aggressive grade 2 and grade 3 gastroenteropancreatic neuroendocr... von Halfdanarson, Thorvardur Ragnar, Reidy, Diane Lauren, Vijayvergia, Namrata, Halperin, Daniel M., Goldstein, Grace, Kong, Grace, Michael, Michael, Leyden, Simone, Grozinsky-Glasberg, Simona, Sorbye, Halfdan, Oberg, Kjell E., Sierras, Cristina, Harris, Philip

Volltext

NETest liquid biopsy is diagnostic of small intestine and pancreatic neuroendocrine tumors and correlates with imaging von Malczewska, Anna, Witkowska, Magdalena, Makulik, Karolina, Bocian, Agnes, Walter, Agata, Pilch-Kowalczyk, Joanna, Zajęcki, Wojciech, Bodei, Lisa, Oberg, Kjell, Kos-Kudła, Beata

Volltext

A meta-analysis of the accuracy of a neuroendocrine tumor mRNA biomarker (NETest) in the blood von Oberg, Kjell E., Califano, Andrea, Strosberg, Jonathan R., Ma, Steven M., Pape, Ulrich-Frank, Bodei, Lisa, Kaltsas, Gregory, Toumpanakis, Christos, Goldenring, James, Frilling, Andreja, Paulson, Andrew Scott, Modlin, Irvin Mark

Volltext

Evaluation of meaningful change in bowel movement frequency for patients with carcinoid syndrome von Hudgens, Stacie, Gable, Jonathon, Kulke, Matthew H., Bergsland, Emily, Anthony, Lowell Brian, Caplin, Martyn E., Oberg, Kjell E., Pavel, Marianne, Banks, Phillip, Yang, Qi Melissa, Lapuerta, Pablo

Volltext

Clinical outcomes in patients with baseline renal dysfunction in the NETTER-1 study: 177Lu-Dotatate vs. high dose octreotide in progressive midgut neuroendocrine tumors von Strosberg, Jonathan R., Wolin, Edward M., Chasen, Beth A., Kulke, Matthew H., Bushnell, David L, Caplin, Martyn E., Baum, Richard P., Hobday, Timothy J., Hendifar, Andrew Eugene, Ravasi, Laura, Oberg, Kjell E., Ruszniewski, Philippe B., Krenning, Eric

Volltext

First update on overall survival, progression-free survival, and health-related time-to-deterioration quality of life from the NETTER-1 study: 177Lu-Dotatate vs. high dose octreoti... von Strosberg, Jonathan R., Wolin, Edward M., Chasen, Beth A., Kulke, Matthew H., Bushnell, David L, Caplin, Martyn E., Baum, Richard P., Hobday, Timothy J., Hendifar, Andrew Eugene, Lopera Sierra, Maribel, Oberg, Kjell E., Ruszniewski, Philippe B., Krenning, Eric

Volltext

Evaluation of meaningful change in bowel move frequency for patients with carcinoid syndrome von Hudgens, Stacie, Gable, Jonathon, Kulke, Matthew H., Bergsland, Emily, Anthony, Lowell Brian, Caplin, Martyn E., Oberg, Kjell E., Pavel, Marianne E., Banks, Phillip, Yang, Qi Melissa, Lapuerta, Pablo

Volltext